Acta Scientific Biotechnology

Short Communication Volume 3 Issue 1

Psoriasis

Harwinder Sidhu*

Department of Biotechnology, New York University, USA

*Corresponding Author: Harwinder Sidhu, Department of Biotechnology, New York University, USA.

Received: February 07, 2022; Published: March 30, 2022

Psoriasis is a chronic autoimmune skin condition with no cure. It goes through cycles of flaring and remission. There is 2% worldwide prevalence of psoriasis out of which 11% Caucasian and Scandinavian population is affected [1]. Asian and African are the least affected populations. It presents at any age. Millions of people worldwide suffer from this disease. It not only leads to physical discomfort but also comes with other comorbidities and mental health disorders. Due to the nature of the disease, individuals often suffer from social anxiety and depression especially with the early onset of the disease. This review focuses on the discussion of causes, pathogenesis and treatment options currently available for psoriasis patients.

References

Citation

Citation: Harwinder Sidhu. “Psoriasis".Acta Scientific Biotechnology 3.1 (2022): 34-36.

Copyright

Copyright: © 2022 Harwinder Sidhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days

Indexed In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US